Picture of Enlivex logo

ENLV Enlivex Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Annual cashflow statement for Enlivex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-14.5-31.1-29.1-151,236
Depreciation
Deferred Taxes
Non-Cash Items-2.265.532.281.72-1,630
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.360.8042.43-0.2610.815
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities-17.5-24-23.5-13-10.4
Capital Expenditures-1.63-8.12-0.236-0.103-0.068
Purchase of Fixed Assets
Other Investing Cash Flow Items-36.870.6-25.79.16-1.25
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-38.462.5-269.06-1.32
Net Issuance / Retirement of Stock
Cash from Financing Activities610.150.366.4510.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4.6238.7-49.12.5-1.36